| Literature DB >> 29470556 |
Magambo Phillip Kimuda1,2, Harry Noyes3, Julius Mulindwa1, John Enyaru4, Vincent Pius Alibu4, Issa Sidibe5, Dieuodonne Mumba Ngoyi6, Christiane Hertz-Fowler3, Annette MacLeod7, Özlem Tastan Bishop2, Enock Matovu1.
Abstract
BACKGROUND: Human African trypanosomiasis (HAT) manifests as an acute form caused by Trypanosoma brucei rhodesiense (Tbr) and a chronic form caused by Trypanosoma brucei gambiense (Tbg). Previous studies have suggested a host genetic role in infection outcomes, particularly for APOL1. We have undertaken candidate gene association studies (CGAS) in a Ugandan Tbr and a Tbg HAT endemic area, to determine whether polymorphisms in IL10, IL8, IL4, HLAG, TNFA, TNX4LB, IL6, IFNG, MIF, APOL1, HLAA, IL1B, IL4R, IL12B, IL12R, HP, HPR, and CFH have a role in HAT. METHODOLOGY ANDEntities:
Mesh:
Substances:
Year: 2018 PMID: 29470556 PMCID: PMC5844566 DOI: 10.1371/journal.pntd.0006300
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
SNPs that showed the lowest p values after association testing with Tbr and Tbg HAT.
| Tbr HAT endemic sample (N = 238; 119 cases, 119 controls) | ||||||||||||||
| 6 | rs9380142 | HLA-G | 29798794 | G | 0.369 | 0.242 | A | 0.003 | 1.834 | 0.1805 | 0.181 | |||
| 6 | rs1233330 | HLA-G | 29799103 | A | 0.076 | 0.136 | G | 0.03 | 0.522 | 1 | 0.541 | |||
| 5 | rs2243283 | IL4 | 132016593 | G | 0.275 | 0.188 | C | 0.04 | 1.644 | 1 | 0.434 | |||
| 22 | rs34383331 | MIF | 24238079 | A | 0.24 | 0.16 | T | 0.03 | 1.657 | 1 | 0.434 | |||
| 22 | rs9282783 | MIF | 24236359 | G | 0.089 | 0.042 | C | 0.033 | 2.227 | 1 | 0.434 | |||
| 6 | rs1800630 | TNFA | 31542476 | A | 0.156 | 0.092 | C | 0.038 | 1.807 | 1 | 0.434 | |||
| 22 | rs73885319 | APOL1 | 36661906 | G | 0.076 | 0.101 | A | 0.339 | 0.730 | 1 | 0.875 | |||
| 22 | rs71785313 | APOL1 | 36662046 | T | 0.081 | 0.086 | A | 0.803 | 0.928 | 1 | 0.9281 | |||
| Tbg HAT endemic sample (N = 202; 99 cases, 103 controls) | ||||||||||||||
| 1 | rs1061170 | CFH | 196659237 | C | 0.409 | 0.525 | T | 0.019 | 0.627 | 1 | 0.611 | |||
| 6 | rs1233330 | HLA-G | 29799103 | A | 0.076 | 0.136 | G | 0.045 | 0.521 | 1 | 0.611 | |||
| 12 | rs78554979 | IFNG | 68554636 | C | 0.051 | 0.015 | T | 0.035 | 3.638 | 1 | 0.611 | |||
| 7 | rs2069843 | IL6 | 22769994 | A | 0.147 | 0.078 | G | 0.033 | 2.038 | 1 | 0.611 | |||
| 22 | rs73885319 | APOL1 | 36661906 | G | 0.015 | 0.015 | A | 0.843 | 1.041 | 0.208 | 5.220 | 1 | 0.898 | |
| 22 | rs71785313 | APOL1 | 36662046 | T | 0.056 | 0.070 | A | 0.612 | 0.782 | 0.346 | 1.766 | 1 | 0.8653 | |
Abbreviations: CHR = Chromosome, SNP = SNP ID, BP = Physical position (base-pair) (Human genome build GRCh37), Allele 1 = Minor allele (based on whole sample), Cases = Frequency of allele 1 in cases, Controls = Frequency of allele 1 in controls, Allele 2 = Major allele, P = p-value for this test, OR = Estimated odds ratio (for Allele 1, i.e. Allele 2 is reference), BONF = Bonferroni single-step adjusted p-values, FDR_BH = Benjamini & Hochberg (1995) step-up FDR control.